Precision Biosciences Inc
Precision Biosciences Inc (DTIL) Option Chain
Read more
Tracking the DTIL option chain helps you see every strike and expiry on Precision Biosciences Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of DTIL options activity at a glance. Use our scanner to monitor the DTIL option chain in real time and filter for the trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For DTIL stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where DTIL options are being actively traded, and where they are not.
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific type of immune cell is genetically engineered to recognize and kill cancer cells; PBCAR0191, which is in Phase 1/2a clinical trial in adult patients with R/R NHL or R/R B-cell precursor acute lymphoblastic leukemia, or B-ALL; PBCAR19B, an anti-CD19 CAR T candidate built on the stealth cell platform utilizing a single-step gene edit to minimize the risk of chromosome abnormalities; and PBCAR269A, an investigational allogeneic CAR T immunotherapy targeting BCMA for the treatment of R/R multiple myeloma.
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 0.00 | 0 | 0 | -0.25 | 4.90 | 2.30 | 7.00 | 2.50 | -63.82 | — | 4.90 | 0.00 | 4.90 | 0 | 0 | 100.00 |
| 0.19 | 3 | 0 | 2.50 | 2.40 | — | 4.90 | 5.00 | -27.64 | — | 4.90 | 0.00 | 4.90 | 0 | 9 | 99.81 |
| 78.89 | 210 | 1 | 0.75 | 0.00 | — | 0.75 | 7.50 | +8.54 | — | 4.90 | 0.10 | 4.80 | 0 | 87 | 21.11 |
| 99.97 | 54 | 0 | 0.50 | 0.00 | — | 0.50 | 10.00 | +44.72 | 0.85 | 3.90 | 2.60 | -0.22 | 1 | 41 | 0.03 |
| 100.00 | 64 | 0 | 1.00 | 0.00 | — | 1.00 | 12.50 | +80.90 | 3.00 | 7.70 | 5.10 | 0.25 | 0 | 20 | 0.00 |
As of Nov 19, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV Rank65.08% Moderate
- Market cap (M$)193
- 52 weeks high-38.80%
- 52 weeks low95.75%
- Analyst recommendationStrong Buy
1.00 - Target price$29.40
297.30% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-03
- P/E—
- Future P/E—
- EPS (ttm)-1.28
- EPS growth next 5 years20.78%
As of Nov 19, 2026